The risk of breast cancer in women with a CHEK2 mutation

The risk of breast cancer in women with a CHEK2 mutation

Bibliographic Details
Main Authors:	Cybulski Cezary, Wokołorczyk Dominika, Jakubowska Anna, Huzarski Tomasz, Byrski Tomasz, Gronwald Jacek, Dębniak Tadeusz, Górski Bohdan, Narod Steven A, Lubiński Jan
Format:	Article
Language:	English
Published:	BMC 2012-01-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/10/S1/A5

Similar Items

CHEK2 mutations as markers for high risk of breast cancer
by: Cybulski Cezary, et al.
Published: (2012-04-01)

Population Screening of CHEK2 Mutations in Poland
by: Cybulski Cezary, et al.
Published: (2006-01-01)

Coverage of the Genetic Background of Breast Cancer in the Polish Population
by: Serrano-Fernández Pablo, et al.
Published: (2006-11-01)

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet
by: Huzarski Tomasz, et al.
Published: (2006-01-01)

<i>BARD1</i> is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation
by: Malwina Suszynska, et al.
Published: (2019-05-01)

Cisplatin in breast cancer treatment in BRCA1 carriers
by: Gronwald Jacek, et al.
Published: (2012-12-01)

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland
by: Emilia Rogoża-Janiszewska, et al.
Published: (2020-08-01)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
by: Muszyńska Magdalena, et al.
Published: (2012-04-01)

Recurrent Mutations in <i>BRCA1</i>,<i> BRCA2</i>,<i> RAD51C</i>,<i> PALB2</i> and <i>CHEK2</i> in Polish Patients with Ovarian Cancer
by: Alicja Łukomska, et al.
Published: (2021-02-01)

The CHEK 2 GENE mutations and the risk of Gastric cancer
by: Teodorczyk Urszula, et al.
Published: (2012-01-01)

Genetic predisposition to male breast cancer in Poland
by: Marek Szwiec, et al.
Published: (2021-08-01)

Iron and breast cancer risk
by: Sukiennicki Grzegorz, et al.
Published: (2012-12-01)

Ovarian cancer risk in Polish <it>BRCA1 </it>mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism
by: Benner Axel, et al.
Published: (2008-04-01)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
by: Sukiennicki Grzegorz, et al.
Published: (2012-04-01)

HOXB13 mutations and prostate cancer in Poland
by: Kluźniak Wojciech, et al.
Published: (2012-12-01)

NBS1 Mutation and prognosis of prostate cancer
by: Wokołorczyk Dominika, et al.
Published: (2012-12-01)

Folic acid and cancer risk in BRCA1 carriers
by: Durda Katarzyna, et al.
Published: (2012-04-01)

Hereditary breast and ovarian cancer
by: Gronwald Jacek, et al.
Published: (2008-06-01)

Selenium and cancer risk in CHEK2 mutation carriers
by: Gupta Satish, et al.
Published: (2012-04-01)

Population Screening for Cancer Family Syndromes in the West Pomeranian Region of Poland
by: Gronwald Jacek, et al.
Published: (2006-01-01)

Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.
by: Núria Bonifaci, et al.
Published: (2010-11-01)

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
by: Byrski T, et al.
Published: (2011-06-01)

Serum Selenium Level Predicts 10-Year Survival after Breast Cancer
by: Marek Szwiec, et al.
Published: (2021-03-01)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
by: Byrski T, et al.
Published: (2012-01-01)

DNA testing for variants conferring low or moderate increase in the risk of cancer
by: Kurzawski Grzegorz, et al.
Published: (2008-06-01)

Prostate cancer screening based on genotyping for high risk founder alleles
by: Cybulski Cezary, et al.
Published: (2012-12-01)

Inherited Variants in <i>BLM</i> and the Risk and Clinical Characteristics of Breast Cancer
by: Wojciech Kluźniak, et al.
Published: (2019-10-01)

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
by: Alena Savanevich, et al.
Published: (2021-01-01)

Zinc and breast cancer risk
by: Kaczmarek Katarzyna, et al.
Published: (2012-12-01)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
by: Jaworska Katarzyna, et al.
Published: (2012-04-01)

Selenium (Se) and breast cancer risk
by: Jaworska - Bieniek Katarzyna, et al.
Published: (2012-12-01)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
by: Byrski T, et al.
Published: (2012-04-01)

The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs
by: Lubiński Jan, et al.
Published: (2005-03-01)

Serum selenium level and cancer risk: a nested case-control study
by: Steven A. Narod, et al.
Published: (2019-12-01)

Current perspectives on CHEK2 mutations in breast cancer
by: Apostolou P, et al.
Published: (2017-05-01)

Blood Arsenic Levels as a Marker of Breast Cancer Risk among <i>BRCA1</i> Carriers
by: Wojciech Marciniak, et al.
Published: (2021-07-01)

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
by: Elżbieta Złowocka-Perłowska, et al.
Published: (2021-01-01)

Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population
by: Katarzyna Białkowska, et al.
Published: (2020-07-01)

Low Blood-As Levels and Selected Genotypes Appears to Be Promising Biomarkers for Occurrence of Colorectal Cancer in Women
by: Piotr Baszuk, et al.
Published: (2021-08-01)

Germline Mutations in CHEK1 and CHEK2 in Women with Ovarian, Peritoneal, or Fallopian Tube Cancer
by: Harrell, Maria Isabel
Published: (2015)